RICHMOND, Va.--(EON: Enhanced Online News)--Altria Group, Inc. (Altria) (NYSE:MO) notes that Philip Morris International Inc. (PMI) today announced the submission of a Modified Risk Tobacco Product (MRTP) application for an electronically heated tobacco product with the U.S. Food and Drug Administration’s (FDA) Center for Tobacco Products. FDA will now determine whether to accept the application for substantive review. Upon regulatory authorization by the FDA, Altria’s companies have an exclusive license to sell this heated tobacco product in the United States.
Altria’s wholly-owned subsidiaries include Philip Morris USA Inc., U.S. Smokeless Tobacco Company LLC, John Middleton Co., Nu Mark LLC, Ste. Michelle Wine Estates Ltd. (Ste. Michelle) and Philip Morris Capital Corporation. Altria holds an equity investment in Anheuser-Busch InBev SA/NV.
The brand portfolios of Altria’s tobacco operating companies include Marlboro®, Black & Mild®, Copenhagen®, Skoal®, MarkTen® and Green Smoke®. Ste. Michelle produces and markets premium wines sold under various labels, including Chateau Ste. Michelle®, Columbia Crest®, 14 Hands® and Stag’s Leap Wine Cellars™, and it imports and markets Antinori®, Champagne Nicolas Feuillatte™, Torres® and Villa Maria Estate™ products in the United States. Trademarks and service marks related to Altria referenced in this release are the property of Altria or its subsidiaries or are used with permission. More information about Altria is available at altria.com and on the Altria Investor app.